These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38193045)

  • 1. Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out.
    Mehic D; Pabinger I; Gebhart J
    Res Pract Thromb Haemost; 2023 Nov; 7(8):102242. PubMed ID: 38193045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion.
    Mehic D; Gebhart J; Pabinger I
    Hamostaseologie; 2024 Aug; 44(4):287-297. PubMed ID: 38412996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C and free protein S in patients with mild to moderate bleeding disorders.
    Mehic D; Schramm T; Forstner-Bergauer B; Haslacher H; Ay C; Pabinger I; Gebhart J
    Thromb Res; 2024 Mar; 235():98-106. PubMed ID: 38324941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life is impaired in bleeding disorders of unknown cause: results from the Vienna Bleeding Biobank.
    Mehic D; Schwarz S; Shulym I; Ay C; Pabinger I; Gebhart J
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102176. PubMed ID: 37720482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research.
    Mezzano D; Quiroga T
    J Thromb Haemost; 2019 Feb; 17(2):257-270. PubMed ID: 30562407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH.
    Baker RI; Choi P; Curry N; Gebhart J; Gomez K; Henskens Y; Heubel-Moenen F; James P; Kadir RA; Kouides P; Lavin M; Lordkipanidze M; Lowe G; Mumford A; Mutch N; Nagler M; Othman M; Pabinger I; Sidonio R; Thomas W; O'Donnell JS;
    J Thromb Haemost; 2024 Jul; 22(7):2059-2070. PubMed ID: 38518896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat bleeding disorder of unknown cause.
    Baker RI; O'Donnell JS
    Blood; 2021 Nov; 138(19):1795-1804. PubMed ID: 34398949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding disorder of unknown cause: Results from Iranian study.
    Zafarani A; Ghodratnia E; Amirzargar MR; Mahmoudi M; Taghavi-Farahabadi M; Tavangar F; Abdolkarimi B; Tabibian S
    Transfus Apher Sci; 2023 Oct; 62(5):103730. PubMed ID: 37295973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause.
    Casini A; Gebhart J
    Int J Lab Hematol; 2024 May; 46 Suppl 1():27-33. PubMed ID: 38454298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB).
    Gebhart J; Hofer S; Panzer S; Quehenberger P; Sunder-Plassmann R; Hoermann G; Eigenbauer E; Haslacher H; Kepa S; Kyrle PA; Eichinger S; Knöbl P; Eischer L; Mannhalter C; Ay C; Pabinger I
    Haemophilia; 2018 May; 24(3):405-413. PubMed ID: 29388750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor.
    Kelly C; Thomas W; Baker RI; O'Donnell JS; Sanchez-Luceros A; Lavin M
    J Thromb Haemost; 2024 Oct; 22(10):2900-2909. PubMed ID: 38866246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank.
    Mehic D; Neubauer G; Janig F; Kaider A; Ay C; Pabinger I; Gebhart J
    J Thromb Haemost; 2023 Jul; 21(7):1757-1768. PubMed ID: 36924834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
    Gupta PK; Charan VD; Saxena R
    Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score.
    Lavin M; Christopherson P; Grabell J; Abshire T; Flood V; Haberichter SL; Lillicrap D; O'Donnell JS; Montgomery RR; James PD
    J Thromb Haemost; 2022 Oct; 20(10):2246-2254. PubMed ID: 35780487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of slightly reduced von Willebrand factor activity.
    Bykowska K; Ceglarek B
    Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Blood Type With Postsurgical Mucosal Bleeding in Pediatric Patients Undergoing Tonsillectomy With or Without Adenoidectomy.
    Archer NM; Forbes PW; Dargie J; Manganella J; Licameli GR; Kenna MA; Brugnara C
    JAMA Netw Open; 2020 Mar; 3(3):e201804. PubMed ID: 32232448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.
    Tosetto A; Badiee Z; Baghaipour MR; Baronciani L; Battle J; Berntorp E; Bodó I; Budde U; Castaman G; Eikenboom JCJ; Eshghi P; Ettorre C; Goodeve A; Goudemand J; Hay CRM; Hoorfar H; Karimi M; Keikhaei B; Lassila R; Leebeek FWG; Lopez Fernandez MF; Mannucci PM; Mazzucconi MG; Morfini M; Oldenburg J; Peake I; Parra Lòpez R; Peyvandi F; Schneppenheim R; Tiede A; Toogeh G; Trossaert M; Zekavat O; Zetterberg EMK; Federici AB
    J Thromb Haemost; 2020 Sep; 18(9):2145-2154. PubMed ID: 32379400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause.
    Mehic D; Assinger A; Gebhart J
    Hamostaseologie; 2024 Oct; 44(5):358-367. PubMed ID: 38950624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.